FDAnews
www.fdanews.com/articles/84626-ann-arbor-firm-with-uw-drug-tech-goes-public

ANN ARBOR FIRM WITH UW DRUG TECH GOES PUBLIC

February 16, 2006

QuatRx Pharmaceuticals Co., a pharmaceutical firm in Ann Arbor, Michigan, that licensed some of University of Wisconsin-Madison professor Hector DeLuca's technology in 2002, has filed for an IPO. One of the company's five products is a treatment for psoriasis, a skin disease, based on DeLuca's work at UW-Madison and Deltanoid Pharmaceuticals. It is licensed through the Wisconsin Alumni Association.
Wisconsin Technology Network